1. About acetylcysteine anaphylaxis

   Comment 09 February 2013 Pages: 2 - 2

2. Nonoxynol 9 irritates the professionals

   Incidence study 09 February 2013 Pages: 2 - 2

3. Watch for late reactions with streptokinase

   Comment 09 February 2013 Pages: 2 - 2

4. Risk of adverse ACE inhibitor effects can be minimised

   Review 09 February 2013 Pages: 3 - 3

5. Algorithm predicts the risk of NSAID-induced GI damage

   Comment 09 February 2013 Pages: 4 - 4

6. Betel-nut bronchoconstriction

   Clinical study 09 February 2013 Pages: 4 - 4

7. Steroid-induced osteoporosis — the role of bone densitometry

   News item 09 February 2013 Pages: 4 - 4

8. The costs of NSAID-induced gastropathy

   Review 09 February 2013 Pages: 4 - 4

9. Alternative medicine

   Case report 09 February 2013 Pages: 5 - 5

10. Amoxicillin + clavulanic acid

    Incidence study 09 February 2013 Pages: 5 - 5

11. Antineoplastics

    Clinical study 09 February 2013 Pages: 5 - 5

12. Antineoplastics/hormones

    Clinical study 09 February 2013 Pages: 5 - 5

13. Antipsychotics

    Case report 09 February 2013 Pages: 5 - 5

14. Drinking milk fortified with cholecalciferol [vitamin D3] may result in hypervitaminosis D

    Case reports 09 February 2013 Pages: 5 - 5

15. Aspirin

    Clinical study 09 February 2013 Pages: 6 - 6

16. Atropine

    Case reports 09 February 2013 Pages: 6 - 6

17. Bleomycin/cisplatin

    Incidence study 09 February 2013 Pages: 6 - 6

18. Brodifacoum overdose

    Case report 09 February 2013 Pages: 6 - 6

19. Bucillamine

    Incidence study 09 February 2013 Pages: 6 - 6

20. Chloroquine

    Case report 09 February 2013 Pages: 6 - 6

21. Chloroquine/proguanil

    Case report 09 February 2013 Pages: 7 - 7

22. Chlorpromazine

    Case report 09 February 2013 Pages: 7 - 7

23. Clozapine

    Case report 09 February 2013 Pages: 7 - 7

24. Clozapine overdose

    Case report 09 February 2013 Pages: 7 - 7

25. Cyclosporin

    Case report 09 February 2013 Pages: 7 - 7

26. Cyclosporin

    Incidence study 09 February 2013 Pages: 8 - 8

27. Cyclosporin interaction

    Clinical study 09 February 2013 Pages: 8 - 8

28. Danazol

    Incidence study 09 February 2013 Pages: 8 - 8

29. Diclofenac/naproxen/tiaprofenic acid

    Case report 09 February 2013 Pages: 8 - 8

30. Didanosine

    Case report 09 February 2013 Pages: 8 - 8

31. Disopyramide

    Case report 09 February 2013 Pages: 8 - 8

32. Disulfiram

    Case report 09 February 2013 Pages: 9 - 9

33. Doxorubicin

    Clinical study 09 February 2013 Pages: 9 - 9

34. Droperidol/fentanyl

    Case report 09 February 2013 Pages: 9 - 9

35. Droxicam/piroxicam/tenoxicam

    Incidence study 09 February 2013 Pages: 9 - 9

36. Enalapril

    Case report 09 February 2013 Pages: 9 - 9

37. Epinephrine

    Case report 09 February 2013 Pages: 9 - 9

38. Estradiol

    Case report 09 February 2013 Pages: 10 - 10

39. Etofenamate

    Case report 09 February 2013 Pages: 10 - 10

40. Gamma hydroxybutyrate

    Case reports 09 February 2013 Pages: 10 - 10

41. Gold

    Clinical study 09 February 2013 Pages: 10 - 10

42. Granulocyte colony-stimulating factor

    Case reports 09 February 2013 Pages: 10 - 10

43. Heparin

    Case report 09 February 2013 Pages: 10 - 10

44. Heparin/warfarin

    Incidence study 09 February 2013 Pages: 10 - 10

45. Hydrochloroquine

    Case report 09 February 2013 Pages: 11 - 11

46. Interferon alpha 2B

    Incidence study 09 February 2013 Pages: 11 - 11

47. Interleukin 2

    Case reports 09 February 2013 Pages: 11 - 11

48. Interleukin 2

    Case report 09 February 2013 Pages: 11 - 11

49. Interleukin 2/interferon alpha

    Case report 09 February 2013 Pages: 11 - 11

50. Isoniazid

    Case report 09 February 2013 Pages: 12 - 12